What this deck covers
This deck focuses on Health Histories And Screenings, giving you a quick way to review the definitions, rules, and examples that matter most for NAPLEX.
Study Health Histories And Screenings in NAPLEX with focused flashcards that help you recognize the idea, recall the key rule, and apply it in practice-style prompts.
0% Complete
What is the primary purpose of obtaining a patient health history in pharmacy practice?
Tap card or press Space to flip
Identify problems, assess risk, and guide safe, effective therapy. This purpose ensures pharmacists can detect drug-related issues, evaluate risks, and optimize treatment plans for patient safety and efficacy.
How well did you know it?
Card 1 / 24
Space to flip · ← / → to move · once flipped, → Got it · ← Still learning
This deck focuses on Health Histories And Screenings, giving you a quick way to review the definitions, rules, and examples that matter most for NAPLEX.
Work through these flashcards in short sessions. Try to answer each prompt before flipping the card, then revisit any cards you miss until the explanation feels automatic.
Answer: Identify problems, assess risk, and guide safe, effective therapy. This purpose ensures pharmacists can detect drug-related issues, evaluate risks, and optimize treatment plans for patient safety and efficacy.
Answer: Random plasma glucose at least 200 mg/dL with symptoms. ADA criteria recognize this level with symptoms like polyuria as diagnostic, prompting immediate diabetes confirmation and treatment.
Answer: A1c at least 6.5%. ADA guidelines establish this threshold as indicative of chronic hyperglycemia, supporting diabetes diagnosis in screening.
Answer: Fasting plasma glucose at least 126 mg/dL. Per ADA criteria, this value confirms hyperglycemia consistent with diabetes, guiding further evaluation and management.
Answer: "What reaction occurred, and how soon after the dose did it start?". This question captures the nature and timing of the reaction, helping differentiate immune-mediated allergies from non-allergic adverse effects.
Answer: BMI 30.0–34.9 kg/m2. WHO classification uses this range to identify moderate obesity, associating it with increased risks for comorbidities like diabetes.
Answer: Full name and date of birth (and a second identifier when available). These identifiers prevent errors in documentation and ensure accurate linkage to the correct patient's medical records as per safety standards.
Answer: BMI=m2kg. This formula standardizes body composition assessment, enabling consistent obesity and health risk evaluation in adults.
Answer: Activate emergency response and refer immediately (call 911). Chest pain may signal acute cardiac events, so immediate emergency activation ensures rapid evaluation and life-saving intervention.
Answer: Onset, Provocation/Palliation, Quality, Region/Radiation, Severity, Time. OPQRST provides a structured framework to thoroughly characterize pain or symptoms, aiding in differential diagnosis and treatment decisions.
Answer: Prior vaccines, dates, reactions, contraindications, and pregnancy/immunocompromise. These elements allow assessment of immunization status, safety, and needs, ensuring appropriate vaccine recommendations.
Answer: OTC drugs, herbals, vitamins/supplements, and PRN products. Including these categories ensures a complete history, identifying potential interactions or contributors to the patient's condition.
Answer: At least 180 systolic or at least 120 diastolic mmHg. Readings at this level indicate potential organ damage, requiring immediate medical attention to prevent stroke or other complications.
Answer: Seated, back supported, feet flat, arm at heart level, correct cuff size. This positioning minimizes measurement errors, ensuring reliable blood pressure readings for accurate hypertension screening.
Answer: Tobacco, alcohol, recreational drugs, diet, and pregnancy intentions. These elements influence drug metabolism, interactions, teratogenicity, and patient education, directly impacting therapeutic choices.
Answer: Sudden "worst headache," neurologic deficit, or signs of meningitis. These symptoms suggest serious conditions like subarachnoid hemorrhage or infection, necessitating urgent medical intervention over self-treatment.
Answer: "What brings you in today?". This open-ended question encourages patients to describe their chief complaint in their own words, facilitating a focused and patient-centered history.
Answer: Drug, reaction description, severity, and timing/onset. Documenting these elements allows for precise risk assessment, differentiation of true allergies, and safe future prescribing decisions.
Answer: Systolic 130–139 mmHg or diastolic 80–89 mmHg. This threshold, per ACC/AHA guidelines, identifies early hypertension for timely intervention and cardiovascular risk reduction.
Answer: GI bleed/ulcer, CKD, ASCVD risk, anticoagulant use, and pregnancy. Screening for these conditions identifies contraindications to NSAIDs, preventing risks like bleeding, renal injury, or fetal harm.
Answer: LDL-C (interpreted with overall ASCVD risk and clinical factors). Guidelines prioritize LDL-C levels alongside ASCVD risk scores to determine statin initiation and intensity for primary prevention.
Answer: Adherence (how the patient actually takes each medication). Assessing adherence reveals discrepancies between prescribed and actual use, enabling accurate interpretation of therapy effectiveness and risks.
Answer: Difficulty breathing, drooling, or inability to swallow fluids. These signs indicate potential airway compromise or severe infection, requiring prompt medical assessment to prevent complications.
Answer: Uncontrolled hypertension (and significant cardiovascular disease). Decongestants can exacerbate hypertension and cardiovascular risks, making this screening essential to avoid adverse events.